Valeant says plans to "improve" offer for Allergan

Send a link to a friend  Share

[May 13, 2014]  (Reuters) Valeant Pharmaceuticals International Inc said it planned to "improve" its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid.

Canada's Valeant said it remained committed to getting the deal done but would remain "financially disciplined."

Allergan, which makes the popular anti-wrinkle treatment Botox, said on Monday that Valeant's business model was unsustainable and the offer was too risky because of uncertainty about the company's long-term growth.

(Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)
 

[to top of second column]

[ 2014 Thomson Reuters. All rights reserved.]

Copyright 2014 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

< Recent articles

Back to top